BMS1 pseudogene 2 (BMS1P2)

BMS1 pseudogene 2 (**BMS1P2**) is a **pseudogene**—a non-protein-coding DNA segment that closely resembles the BMS1 ribosome biogenesis factor gene but does not encode a functional protein[5]. It is classified as a processed pseudogene and is listed in genomic databases as a non-coding locus. BMS1P2 has multiple alternative names and former identifiers but is not classified as a therapeutic target since it is not known to produce a functional protein or RNA with a well-defined biological function[5]. There is no direct evidence linking BMS1P2 to specific biological processes or human diseases, nor is it currently a known biomarker or therapeutic target[5]. Most literature and database entries confirm its categorization as a genomic pseudogene without established functionality or clinical significance. **Rationale for 'is_incorrect: true':** - BMS1P2 is not a receptor, enzyme, transporter, or any other typical drug target. - There is no direct implication in disease, no evidence for interaction with therapeutics, and it does not encode a protein. - Its classification as a pseudogene means that, while it may produce noncoding RNA, there is no clear evidence it functions in a therapeutic or diagnostic context[5]. **Context regarding disease association and pseudogenes:** - Some pseudogenes are investigated for potential regulatory roles (such as acting as miRNA sponges), but there is no specific evidence presented for BMS1P2 fulfilling such a role. - Other BMS1 pseudogenes (e.g., BMS1P20) have been investigated for correlations with cancer profiles[7], but BMS1P2 has not been highlighted in this context. **Summary:** BMS1P2 is a processed pseudogene, not a functional protein, receptor, or therapeutic target. It serves primarily as a genomic marker without current translational or clinical utility[5].

Other names

bA144G6.1OTTHUMG00000018113bA302K17.2OTTHUMG00000018142BMS1LP2BMS1P6BMS1LP6